{
  "trial_id": "NCT02428855",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, ECOG performance status, IDH mutation status (IDH1 or IDH2), prior treatment history (including prior platinum-based regimen and prior chemoembolization, radiofrequency ablation, or radiation), measurable disease status, absolute neutrophil count, platelet count, hemoglobin level, total bilirubin level, AST (SGOT)/ALT (SGPT) levels, PT/PTT levels, creatinine level or GFR, serum albumin level, life expectancy, presence of brain metastases, cardiovascular history (including congestive heart failure, hypertension, cardiac arrhythmias, stroke, myocardial infarction, thromboembolic events), history of other clinically significant disorders (such as active infection, non-healing wounds, pleural effusions, pulmonary arterial hypertension), concurrent malignancy status, psychiatric history, HIV status, pregnancy status, ability to swallow tablets.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "IDH Mutation",
          "IDH mutation status (IDH1 or IDH2)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "Tumor location"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "prior treatment history (including prior platinum-based regimen and prior chemoembolization, radiofrequency ablation, or radiation)",
        "measurable disease status",
        "absolute neutrophil count",
        "platelet count",
        "hemoglobin level",
        "total bilirubin level",
        "AST (SGOT)/ALT (SGPT) levels",
        "PT/PTT levels",
        "creatinine level or GFR",
        "serum albumin level",
        "life expectancy",
        "presence of brain metastases",
        "cardiovascular history (including congestive heart failure, hypertension, cardiac arrhythmias, stroke, myocardial infarction, thromboembolic events)",
        "history of other clinically significant disorders (such as active infection, non-healing wounds, pleural effusions, pulmonary arterial hypertension)",
        "concurrent malignancy status",
        "psychiatric history",
        "HIV status",
        "pregnancy status",
        "ability to swallow tablets"
      ]
    },
    "processed-gen-response": "Age, sex, ECOG performance status, IDH mutation status (IDH1 or IDH2), prior treatment history (including prior platinum-based regimen and prior chemoembolization, radiofrequency ablation, or radiation), measurable disease status, absolute neutrophil count, platelet count, hemoglobin level, total bilirubin level, AST (SGOT)/ALT (SGPT) levels, PT/PTT levels, creatinine level or GFR, serum albumin level, life expectancy, presence of brain metastases, cardiovascular history (including congestive heart failure, hypertension, cardiac arrhythmias, stroke, myocardial infarction, thromboembolic events), history of other clinically significant disorders (such as active infection, non-healing wounds, pleural effusions, pulmonary arterial hypertension), concurrent malignancy status, psychiatric history, HIV status, pregnancy status, ability to swallow tablets."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG performance status, Absolute neutrophil count, Platelets, Hemoglobin, Total bilirubin, AST (SGOT)/ALT (SGPT), PT/PTT, Creatinine, Serum Albumin, Prior treatment history, IDH mutation status, Measurable disease status,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "IDH Mutation",
          "IDH mutation status"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected",
        "Tumor location"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "ECOG performance status",
        "Absolute neutrophil count",
        "Platelets",
        "Hemoglobin",
        "Total bilirubin",
        "AST (SGOT)/ALT (SGPT)",
        "PT/PTT",
        "Creatinine",
        "Serum Albumin",
        "Prior treatment history",
        "Measurable disease status"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG performance status, Absolute neutrophil count, Platelets, Hemoglobin, Total bilirubin, AST (SGOT)/ALT (SGPT), PT/PTT, Creatinine, Serum Albumin, Prior treatment history, IDH mutation status, Measurable disease status"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, IDH1 or IDH2 mutation status, Prior platinum-based regimen, Measurable disease, Absolute neutrophil count, Platelets, Hemoglobin, Total bilirubin, AST (SGOT)/ALT (SGPT), PT/PTT, Creatinine, Serum Albumin.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "IDH Mutation",
          "IDH1 or IDH2 mutation status"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected",
        "Tumor location"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "ECOG Performance Status",
        "Prior platinum-based regimen",
        "Measurable disease",
        "Absolute neutrophil count",
        "Platelets",
        "Hemoglobin",
        "Total bilirubin",
        "AST (SGOT)/ALT (SGPT)",
        "PT/PTT",
        "Creatinine",
        "Serum Albumin"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, IDH1 or IDH2 mutation status, Prior platinum-based regimen, Measurable disease, Absolute neutrophil count, Platelets, Hemoglobin, Total bilirubin, AST (SGOT)/ALT (SGPT), PT/PTT, Creatinine, Serum Albumin."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ECOG performance status, life expectancy, IDH mutation status, prior platinum-based regimen, measurable disease, absolute neutrophil count, platelets, hemoglobin, total bilirubin, AST, ALT, PT, PTT, creatinine, GFR, serum albumin.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "IDH Mutation",
          "IDH mutation status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "Tumor location"
      ],
      "remaining_candidate_features": [
        "race",
        "ECOG performance status",
        "life expectancy",
        "prior platinum-based regimen",
        "measurable disease",
        "absolute neutrophil count",
        "platelets",
        "hemoglobin",
        "total bilirubin",
        "AST",
        "ALT",
        "PT",
        "PTT",
        "creatinine",
        "GFR",
        "serum albumin"
      ]
    },
    "processed-gen-response": "Age, sex, race, ECOG performance status, life expectancy, IDH mutation status, prior platinum-based regimen, measurable disease, absolute neutrophil count, platelets, hemoglobin, total bilirubin, AST, ALT, PT, PTT, creatinine, GFR, serum albumin."
  }
}